Jyotsna R. Sandil, M.D.

Dr. Jyotsna Sandil joined the Drug Regulatory Group of the Regulatory Affairs Branch at CTEP in March 2023. She manages the Investigational New Drug Applications (IND) for a complex portfolio of the investigational agents and facilitates FDA communications related to that portfolio. She provides regulatory support to CTEP, NCI, investigators, and pharmaceutical collaborators.

Dr. Sandil received her M.D. from Kuban State Medical Academy in Russia and worked as a medical resident officer in India. In the U.S., she served as a clinical research coordinator and senior clinical research manager for over a decade prior to joining CTEP, preparing IRB submissions, protocol revisions, and renewals, and ensuring institutional compliance with FDA and USDA regulations.